Skip to main content
Premium Trial:

Request an Annual Quote

Ambion: Jul 13, 2006

Premium

Ambion recently introduced its mirVana miRNA bioarrays V2, a version of the company's microRNA microarrays that includes probes targeting an exclusive set of 152 newly identified human miRNAs.

The new bioarrays also feature 22 control probes, the company said.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.